Operating result (€ million) | 1,039 | 1.009 | 885 | 858 | 749 |
IFRS net result (€ million) | 733 | 942 | 657 | 972 | 669 |
Operating return on equity (%) | 12.8 | 16.3 | 15.3 | 15.1 | 14.3 |
IFRS return on equity (%) | 11.3 | 15.3 | 11.7 | 19.1 | 13.7 |
Solvency II ratio (standard formula) (%) | 222 | 196 | 199 | 194 | 197 |
Dividend per share (€) | 2.70 | 2.42 | 2.04 | 1.90 | 1.74 |
Total dividend (€ million) | 386 | 329 | 282 | 267 | 245 |
Share buyback (€ million) | 75 | 75 | 75 | 13 | - |
Total equity (€ million) | 6,753 | 7,385 | 6,313 | 6,093 | 5,479 |
Total equity attributable to shareholders (€ million) | 6,722 | 6,363 | 5,309 | 5,089 | 4,478 |
Gross written premiums (€ million) | 6,041 | 5.859 | 5,276 | 4,666 | 4,459 |
New business Life segment (APE) (€ million) | 127 | 151 | 124 | 159 | 119 |
Operating expenses (€ million) | -779 | -725 | -701 | - 656 | - 601 |
Combined ratio (Non-life segment) (%) | 91.7 | 91.8 | 93.6 | 93.5 | 95.7 |
Credit rating (S&P) | A | A | A | A | A |
Organic capital creation (€ million) | 653 | 594 | 500 | 501 | 372 |
Interest coverage ratio (%) | 9.9 | 13.8 | 9.5 | 12.9 | 10.9 |